“Our molecular biology team and laboratory management have been working intensively in the past few weeks in order to establish a validated testing infrastructure in our facilities despite bottlenecks in the global supply chain,” explained Dr. Michael Stelzl, CEO of Hygienicum GmbH. “We are continuously in communication with the responsible agencies and authorities. We care deeply about using our services in order to make an important contribution towards curbing the effects of the Corona crisis in Austria.”
The recently finalized expansion of the Hygienicum site in Graz helped facilitate the establishment of the new testing infrastructure. That made it possible to keep the COVID-19 analyses isolated from other business activities and use part of the new facility exclusively for critical samples from the medical and pharmaceutical field.
The GBA Group, founded in 1989, brings together a network of dynamic companies providing laboratory analysis and related services to customers in three major sectors: food, environment, and pharmaceuticals. The focus is on providing solutions that meet the needs of the customers in combination with scientific and technical expertise. The expert employees maintain a strong emphasis on providing high-quality service by communicating with customers intensively.
GBA GROUP
Goldtschmidtstraße 5
21073 Hamburg
Telefon: +49 (40) 797172-0
Telefax: +49 (40) 797172-27
https://www.gba-group.com
Head of Corporate Communication
E-Mail: presse@gba-group.de
